ライフサイエンスコーパス: tobacco smoking

1 hrenia is associated with very high rates of tobacco smoking.

2 , for example, the "pack-years" variable for tobacco smoking.

3 tational signatures that are associated with tobacco smoking.

4 diseases, respectively, were attributable to tobacco smoking.

5 models adjusted for age, sex, and cumulative tobacco smoking.

6 increased with each additional pack-year of tobacco smoking.

7 Risk factors for periodontal disease include tobacco smoking.

8 r levels by 6 to 12 weeks of abstinence from tobacco smoking.

9 xplore the mutational burden associated with tobacco smoking.

10 is a major cause for starting or increasing tobacco smoking.

11 ntribute to the perpetuation of addiction to tobacco smoking.

12 on between the level of fasting glycemia and tobacco smoking.

13 ich despite some success have not eliminated tobacco smoking.

14 use of death, and almost all of it is due to tobacco smoking.

15 the youngest infants and in those exposed to tobacco smoking.

16 exposure of the upper aerodigestive tract to tobacco smoking.

17 on with the effect of nonsmoking and regular tobacco smoking.

18 sted waist-to-hip ratio, alcohol intake, and tobacco smoking.

19 of the genetic effect of body mass index and tobacco smoking.

20 inconclusive due to confounding by previous tobacco smoking.

21 a indicate that vaping may not be safer than tobacco smoking.

22 ically involved in the reinforcing effect of tobacco smoking.

23 x disease, Barrett's esophagus, obesity, and tobacco smoking.

24 ion treatments and reduce the harm caused by tobacco smoking.

25 association with risk for IBD is modified by tobacco smoking.

26 t disease, diseases strongly associated with tobacco smoking.

27 , but this does not seem to be made worse by tobacco smoking.

28 ical tumors and that LOY could be induced by tobacco smoking.

29 e, the principal addictive component driving tobacco smoking.

30 geting prevention and cessation of waterpipe tobacco smoking.

31 ntified strong epigenetic signals related to tobacco smoking.

32 (beta +/- SE 0.07 +/- 0.01; P < 0.0001) and tobacco smoking (0.64 +/- 0.26; P = 0.016), as well as w

33 risk ratio [RR] 1.41 [95% CI 1.26-1.57]) and tobacco smoking (1.46 [1.30-1.65]) than in HIV-negative

34 use (RR 1.36 [95% CI 1.10-1.69]; p=0.0050), tobacco smoking (1.90 [1.38-2.62]; p<0.0001), and smokel

35 positive women was 1.3% (95% CI 0.8-1.9) for tobacco smoking, 2.1% (1.1-3.4) for smokeless tobacco us

36 Tobacco smoking (3.806, one degree of freedom; P < .015,

37 ositive men was 24.4% (95% CI 21.1-27.8) for tobacco smoking, 3.4% (1.8-5.6) for smokeless tobacco us

38 SBS4, which has previously been linked with tobacco smoking(9), and a 76% increase in the clock-like

39 The primary outcome was 7 months continuous tobacco smoking abstinence as measured at 9 months after

40 In 2004, active tobacco smoking accounted for approximately 15.8% (95% C

41 Although tobacco smoking accounts for the majority of lung cancer

42 e no significant differences in gender, age, tobacco smoking, Acute Physiology and Chronic Health Eva

43 st associations, with the exception of daily tobacco smoking (adjusted OR 1.74, 95% CI 1.08-2.81), an

44 There is growing evidence that water pipe tobacco smoking affects heart rate, blood pressure regul

45 2 therapy was influenced by PPD at baseline, tobacco smoking, age, and type of tooth.

46 y (aHR = 2.757 [1.616-4.704], p < 0.001) and tobacco smoking (aHR = 2.150 [1.319-3.503], p < 0.01) we

47 lected on education, household overcrowding, tobacco smoking, alcohol and drugs use, and history of h

48 adult exposures to carcinogens, such as from tobacco smoking, alcohol consumption and various industr

49 rders in general), including breast-feeding, tobacco smoking, alcohol consumption, and exposure to do

50 ,115) and tested the association of RBA with tobacco smoking, alcohol consumption, and genetic varian

51 extensive questionnaire containing items on tobacco smoking, alcohol consumption, and occupational e

52 gnancy was identified based on self-reported tobacco smoking, alcohol consumption, and use of cannabi

53 sion models that were adjusted for age, sex, tobacco smoking, alcohol drinking, and hypertension.

54 terms for age, sex, study center, education, tobacco smoking, alcohol drinking, hepatitis B surface a

55 Given the coincident use of tobacco smoking among HIV-infected intravenous drug user

56 ze existing data on the prevalence of active tobacco smoking among patients with hypertension or diab

57 Heavier tobacco smoking among people with schizophrenia (SCZ) ha

58 from the general population, in relation to tobacco smoking, an exposure with well-characterised hea

59 o specific risk factors, such as alcohol and tobacco (smoking and smokeless), but dietary factors and

60 nicotine accumulates in the intestine during tobacco smoking and activates intestinal AMPKalpha.

61 Rationale: Tobacco smoking and air pollution are primary causes of

62 ted with the widely accepted risk factors of tobacco smoking and alcohol use and is the end result of

63 ants of health (SDHs, including drug misuse, tobacco smoking and alcohol), and TB, taking into accoun

64 mokers to assess whether baseline water pipe tobacco smoking and baseline snus use were associated wi

65 models to assess whether baseline water pipe tobacco smoking and baseline snus use were associated wi

66 or numerous potential confounders, including tobacco smoking and C-reactive protein levels.

67 Both tobacco smoking and circulating cardiac troponin I (cTnI

68 population density areas, and pack-years of tobacco smoking and decreases in subjects with history o

69 Outcomes were current tobacco smoking and e-cigarette use.

70 We studied the association between tobacco smoking and epigenome-wide methylation in non-tu

71 Tobacco smoking and female sex were associated with high

72 rience co-occurring substance use, including tobacco smoking and heavy cannabis use, and substance us

73 h decreased risk of ADA development, whereas tobacco smoking and infections during the study were ass

74 the documentation of an association between tobacco smoking and lung cancer.

75 anged by at least 2 percentage points (e.g., tobacco smoking and mental health conditions) were assoc

76 s to investigate the differential effects of tobacco smoking and nicotine on changes in GABAA recepto

77 fidence intervals, controlling for age, sex, tobacco smoking and opium usage history, alcohol consump

78 We investigated whether tobacco smoking and other factors increase risk for Barr

79 and 95% confidence intervals, adjusting for tobacco smoking and other potential confounders.

80 childhood behavior might reduce early onset tobacco smoking and risk of tobacco dependence among smo

81 This study examined the associations between tobacco smoking and serum cotinine levels, an objective

82 Tobacco smoking and smoke exposure during pregnancy and

83 t in the neurochemical mechanisms underlying tobacco smoking and smoking-related behaviors.

84 emographic risk factors, baseline water pipe tobacco smoking and snus use were independently associat

85 Aware of the negative consequences of tobacco smoking and the challenges of smoking cessation,

86 Water pipe tobacco smoking and the use of snus at baseline.

87 Water pipe tobacco smoking and the use of snus independently predic

88 HIV-infected men ages 40-60, independent of tobacco smoking and traditional risk factors.

89 , physical activity, nutrition, alcohol, and tobacco smoking) and were ranked based on how frequently

90 Clinician type, tobacco smoking, and age may be important clinical facto

91 pollutants, built environment, green spaces, tobacco smoking, and biomarkers of chemical pollutants (

92 Risk factors for CRC in Africa include tobacco smoking, and consumption of red meat, butter, an

93 , age, height, weight, total caloric intake, tobacco smoking, and education.

94 Obesity, tobacco smoking, and genetic predisposition increase the

95 G included short maternal stature (<145 cm), tobacco smoking, and HIV infection.

96 in England, including through drugs misuse, tobacco smoking, and homelessness.

97 rhosis, diabetes, obesity, alcohol drinking, tobacco smoking, and host genetic polymorphisms.

98 had higher body mass index, a higher rate of tobacco smoking, and lower lung function.

99 Associations of cognitive function, obesity, tobacco smoking, and medical conditions with natural cau

100 scular risk factors: hypertension, diabetes, tobacco smoking, and obesity across 230 cities in six co

101 obiome were observed with poor oral hygiene, tobacco smoking, and oral cancer.

102 residualization, adjusting for air nicotine, tobacco smoking, and other air particle generating or ve

103 le), past-month binge alcohol use, past-year tobacco smoking, and past-year suicidal ideation or suic

104 rence, body mass index, alcohol consumption, tobacco smoking, and physical activity.

105 es regarded as a less harmful alternative to tobacco smoking, and there is some evidence of their pot

106 for recurrent reflux, body mass index (BMI), tobacco smoking, and type of antireflux surgery.

107 enitor-like cells likely due to the combined tobacco smoking- and APOBEC3A-associated DNA damage and

108 sociated with >2 times the odds of taking up tobacco smoking [aOR 2.33, 1.28-4.24]).

109 decrement: 1.02 (95% CI 1.01-1.03)], current tobacco smoking [aOR versus never: 1.81 (95% CI 1.26-2.5

110 al interventions to reduce alcohol abuse and tobacco smoking are also needed.

111 Life-course persistent asthma and tobacco smoking are risk factors for irreversible airflo

112 al cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explai

113 tablished risk factors, that is, obesity and tobacco smoking, are overrepresented among patients who

114 in Nha Trang, Vietnam, to evaluate paternal tobacco smoking as a risk factor for infectious and non-

115 Results show tobacco smoking as a risk factor for oral HPV among PLWH

116 Current cannabis use and tobacco smoking, as documented in the medical encounter.

117 tios (HRs) for lung cancer incidence by sex, tobacco smoking, asbestos exposure, presence of asbestos

118 Aberrant AID/APOBEC activity-associated and tobacco smoking-associated mutational signatures were re

119 s conducted at the Clinical Research Lab for Tobacco Smoking at Florida International University in M

120 bladder cancers are chemically induced, with tobacco smoking being the leading risk factor.

121 nd non-communicable diseases); health risks (tobacco smoking, binge drinking, overweight, and anaemia

122 are hypothesized to contribute to relapse to tobacco smoking but mechanisms underlying and linking su

123 5 million deaths a year are attributable to tobacco smoking, but attempts to help people either quit

124 Modeled age-standardized prevalence of daily tobacco smoking by age, sex, country, and year; cigarett

125 nicotine consumption and prevent relapse to tobacco smoking by modulating glutamate transmission.

126 The rates of tobacco smoking by people living with HIV vastly exceed

127 Tobacco smoking can account for some of the excess morta

128 Epidemiological studies indicate that tobacco smoking can be protective against neurodegenerat

129 Although residual confounding by tobacco smoking cannot be ruled out, this finding may re

130 Tobacco smoking causes lung cancer(1-3), a process that

131 important aim in public health worldwide as tobacco smoking causes many preventable deaths.

132 the evidence on the use of e-cigarettes for tobacco smoking cessation in adults, including pregnant

133 vidence on pharmacotherapy interventions for tobacco smoking cessation in pregnant persons is insuffi

134 net benefit of behavioral interventions for tobacco smoking cessation on perinatal outcomes and smok

135 F reviewed the evidence on interventions for tobacco smoking cessation that are relevant to primary c

136 ssociated (FDA)-approved pharmacotherapy for tobacco smoking cessation, alone or combined, in nonpreg

137 hanism contributing to its ability to aid in tobacco smoking cessation.

138 obstructive pulmonary disease (COPD) due to tobacco smoking commonly presents when extensive lung da

139 Tobacco smoking compromises the prognosis of dental impl

140 thylation in 5243 cancers of types for which tobacco smoking confers an elevated risk.

141 Known signatures of tobacco smoking correlated with tobacco consumption, but

142 DNA adducts associated with tobacco smoking could provide a marker of biologically e

143 ibutable and unattributable to hypertension, tobacco smoking, diabetes mellitus, and obesity using an

144 Data on lifetime tobacco smoking, diet, education, and anthropometric mea

145 Hazardous lifestyle choices (notably tobacco smoking) differ in prevalence between genders, a

146 These findings demonstrate that tobacco smoking differentially affects the mesocortical

147 Tobacco smoking, driven by the addictive properties of n

148 losis risk was independently associated with tobacco smoking, drugs use (especially injectable drugs

149 has been reported that pre-conditioning with tobacco smoking during adolescence predisposes those you

150 y through year-4 and by frequent exposure to tobacco smoking during chemotherapy.

151 Associations between tobacco smoking during pregnancy and offspring asthma ha

152 Tobacco smoking during this age can compromise the norma

153 ChRs) may underlie differential nicotine and tobacco smoking effects and related behaviors in women v

154 e and other risk factor trends continue, the Tobacco Smoking Elimination as of 2023 scenario quantifi

155 ng prevalence from 2023 onwards, whereas the Tobacco Smoking Elimination by 2050 scenario provides es

156 Tobacco smoking enhances peri-implant soft tissue inflam

157 nd chemotherapy-responsive tumor, related to tobacco smoking, environmental arsenic exposure, industr

158 findings suggest a possible route to reduce tobacco smoking-exacerbated NAFLD progression.

159 divergent evolutionary trajectories based on tobacco smoking exposure, ancestry and sex.

160 ding age, sex, genetic ancestry, second-hand tobacco smoking exposure, LCINS histology, stage, and ov

161 ss the world, reflecting varying patterns of tobacco smoking, exposure to environmental risk factors

162 t risk reduction, followed by a reduction in tobacco smoking for men and obesity for women, but these

163 ine is clearly recognized by the tenacity of tobacco smoking for most users, and has prompted extensi

164 variety of psychiatric disorders, including tobacco smoking, for which there is strong evidence supp

165 % confidence interval [CI], 1.7-49.3), heavy tobacco smoking (>20 pack-years vs none; OR, 9.2; 95% CI

166 ught to be the key substance responsible for tobacco-smoking habits and appears to trigger reinforcem

167 Cigarette and alternative tobacco smoking had a significant impact on the supragin

168 The spread of water pipe tobacco smoking has been abetted by the marketing of fla

169 Tobacco smoking has been associated with impaired pulmon

170 Tobacco smoking has been demonstrated to increase the ri

171 Tobacco smoking has been linked to an increased risk of

172 Tobacco smoking has many adverse health consequences.

173 Exposure to direct and passive tobacco smoking has significant impact on the gingival a

174 (reflux), higher body mass index (BMI), and tobacco smoking have been individually associated with e

175 factors related to DALYs were dietary risks, tobacco smoking, high body mass index, high blood pressu

176 Cumulative tobacco smoking histories and spirometry were obtained a

177 N3), Zubrod performance status (0 vs 1), and tobacco smoking history (<=10 pack-years vs >10 pack-yea

178 A 62-year-old man with a 45 pack per year tobacco-smoking history presented with painless gross he

179 CI, 1.83-4.47; z = 4.62; adjusted P < .001), tobacco smoking (HR, 2.26; 95% CI, 1.55-3.30; z = 4.23;

180 Traditional risk factors were tobacco smoking, hypertension, elevated total cholestero

181 ars (wave 10), mental health problems, daily tobacco smoking, illicit drug use, and dependence were a

182 ioural risk factors were unhealthy diets and tobacco smoking in 2015.

183 ne, a noradrenergic alpha2a agonist, reduced tobacco smoking in a 4-week trial and in animal models h

184 2030, which means reducing the prevalence of tobacco smoking in adults to 5% by then.

185 elated neuroadaptations of cAMP signaling to tobacco smoking in human subjects and suggest that smoki

186 The pooled prevalence of current tobacco smoking in pregnant women ranged from 0.6% (0.3-

187 interactions between FLG null mutations and tobacco smoking in relation to asthma.

188 modeled age-standardized prevalence of daily tobacco smoking in the population older than 15 years de

189 lysis of covariance with age (in months) and tobacco smoking (in pack-years) as covariates showed tha

190 from solid fuels (HAP; 7.0% [5.6-8.3]), and tobacco smoking including second-hand smoke (6.1% [5.4-6

191 ertainty interval 6.2-7.7] of global DALYs), tobacco smoking including second-hand smoke (6.3% [5.5-7

192 Despite declines, tobacco smoking including second-hand smoke remained the

193 Thus, tobacco smoking increases mutational burden, cell-to-cel

194 Tobacco smoking increases the risk of at least 17 classe

195 These results provide further support that tobacco smoking increases the risk of developing aortic

196 Paternal tobacco smoking independently increased the risk of LRTI

197 tors, such as the microbiome, nutrition, and tobacco smoking, induce alterations in the epigenome of

198 ]PHNO PET may be more sensitive to measuring tobacco smoking-induced DA release in human tobacco smok

199 latory effects of nicotine in the brain (ie, tobacco smoking-induced upregulation of beta(2)*-nAChRs)

200 ttributable risk (PAR) of bladder cancer for tobacco smoking is 50% to 65% in men and 20% to 30% in w

201 Tobacco smoking is a chronic, relapsing disorder that co

202 Tobacco smoking is a major risk factor for many diseases

203 Tobacco smoking is a risk factor for numerous disorders,

204 Tobacco smoking is a well-known risk factor for subseque

205 Tobacco smoking is a worldwide public health problem.

206 Tobacco smoking is associated with a substantially eleva

207 Tobacco smoking is associated with chronic obstructive p

208 Tobacco smoking is associated with differential methylat

209 Parental tobacco smoking is associated with lower airway function

210 Tobacco smoking is common in HIV-infected patients, and

211 Tobacco smoking is considered a major modifiable risk fa

212 Once dependence on tobacco smoking is established, evidence suggests that t

213 Tobacco smoking is frequently abused by schizophrenia pa

214 Waterpipe tobacco smoking is growing in popularity despite adverse

215 Tobacco smoking is highly addictive and causes respirato

216 ented in countries where ETS due to maternal tobacco smoking is negligible.

217 Tobacco smoking is the dominant risk factor for chronic

218 Tobacco smoking is the leading cause but not the only on

219 Tobacco smoking is the leading cause of preventable deat

220 Tobacco smoking is the leading risk factor for bladder c

221 Tobacco smoking is the major cause of lung cancer, and p

222 Tobacco smoking is the most important and well-establish

223 Worldwide, tobacco smoking is the principal lifestyle exposure that

224 Although tobacco smoking is well-known to increase esophageal aci

225 ove to be one of the key mechanisms by which tobacco smoking leads to increased periodontitis suscept

226 Our results suggest that tobacco smoking may alter the genetic susceptibility to

227 to help them quit, the benefits of quitting tobacco smoking may outweigh any negative oral health im

228 Tobacco smoking may play an important role in both the o

229 s study was to investigate whether different tobacco smoking metrics and smoking cessation was associ

230 ing that there are various pathways by which tobacco smoking might contribute to development of Barre

231 tients with lung cancer report no history of tobacco smoking (never-smokers).

232 Tobacco smoking, nicotine in particular, is one of the r

233 At blood levels comparable with tobacco smoking, nicotine infusion does not appear to al

234 lcohol withdrawal with or without concurrent tobacco smoking/nicotine consumption resulted in signifi

235 e, calendar period, and diagnoses related to tobacco smoking, obesity, and alcohol overconsumption.

236 Besides tobacco smoking, occupation, and other factors, diet may

237 e disorders, the most robust risk factor was tobacco smoking (odds ratio, OR=3.07).

238 Understanding the effects of tobacco smoking on neuroadaptations in GABAA receptor le

239 needed to fully characterize the effects of tobacco smoking on the brain immune system.

240 The effects of tobacco smoking on the immune system of the brain are no

241 risk, we sought to investigate the impact of tobacco smoking on the risk of premature death and its c

242 ere we report on the sex-specific effects of tobacco smoking on transcriptomic and epigenetic feature

243 These associations were not attributable to tobacco smoking or clozapine medication.

244 -base substitutions were generated by either tobacco smoking or exposure to ultraviolet light.

245 cancers, which could indicate confounding by tobacco smoking or reverse causality.

246 secondary causes of erythrocytosis, such as tobacco smoking or sleep apnea.

247 In contrast, tobacco smoking (OR = 0.96, 95% CI: 0.36-2.55), alcohol

248 This blunting may contribute to relapse to tobacco smoking, particularly in depression-vulnerable i

249 er among males and females reflect differing tobacco smoking patterns.

250 moking status, demographics, alcohol intake, tobacco smoking, physical activity, and included a food-

251 ome variable (the percentage point change in tobacco smoking prevalence between 2005 and 2015).

252 and a 96.6% response rate, found an overall tobacco smoking prevalence of 19.4%, with higher rates a

253 Higher tobacco smoking, psychosis, and diabetes ES were found i

254 problems later in life, we generated ES for tobacco smoking, psychosis, autism, diabetes, and obesit

255 ver, this excess risk may be attributable to tobacco smoking rather than the three-fold higher preval

256 D (chronic obstructive pulmonary disease), a tobacco smoking-related disease.

257 that acrolein is a major etiologic agent for tobacco smoking-related lung cancer.

258 We sought to quantify the burden of tobacco-smoking-related deaths in Asia, in parts of whic

259 Tobacco smoking remains an important public health issue

260 Tobacco smoking represents the leading preventable cause

261 0.9-4.0) for 29 to 39 years and >39 years of tobacco smoking, respectively, as compared with those th

262 Addiction to tobacco smoking results from the binding of nicotine to

263 significantly increase risk for SP included tobacco smoking (RR, 2.47; 95% CI, 2.12-2.87), alcohol i

264 her odds of lung cancer after adjustment for tobacco smoking, serum cotinine levels, educational atta

265 No strong tobacco smoking signatures were detected, even in cases

266 , and overall relative prevalence ratios for tobacco smoking, smokeless tobacco use, and any tobacco

267 To assess how tobacco smoking status affects baseline dopamine D2/D3 (

268 gender, age at time of initial examination, tobacco smoking status at time of initial examination, p

269 l confounders, particularly body mass index, tobacco smoking status, and socioeconomic status, part o

270 e likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders,

271 y factors, including childhood maltreatment, tobacco smoking, substance dependence, psychiatric medic

272 a substantial decrease in the prevalence of tobacco smoking, the adverse health effects of tobacco s

273 s of four factors: HPV status, pack-years of tobacco smoking, tumor stage, and nodal stage.

274 Chronic exposure to nicotine, as in tobacco smoking, up-regulates nicotinic acetylcholine re

275 and cause-specific mortality associated with tobacco smoking using adjusted hazard ratios and their 9

276 CI, 0.82-1.14, P = .69) after adjusting for tobacco smoking, vaccination, comorbidity, diagnosis dat

277 between ages 40-60 after adjusting for age, tobacco smoking, viral load, and traditional risk factor

278 ts with validated continuous abstinence from tobacco smoking was 28.9% in the intervention group and

279 studies established for the first time that tobacco smoking was a risk factor for the development of

280 r, prevalence of psychiatric comorbidity and tobacco smoking was alarmingly high in severe patients w

281 healthy infants whether exposure to parental tobacco smoking was associated with airway hyperreactivi

282 Parental tobacco smoking was associated with lower baseline airwa

283 Tobacco smoking was associated with treatment escalation

284 In the PATH Study, combustible tobacco smoking was consistently associated with lifetim

285 istories, the mutational signature caused by tobacco smoking was essentially absent in NSRO-driven NS

286 The strongest association with tobacco smoking was found for lung cancer: a 3- to 4-fol

287 Current tobacco smoking was reported at one or more timepoints b

288 Current tobacco smoking was significantly associated with an inc

289 Current tobacco smoking was significantly associated with increa

290 Thus, tobacco smoking was the main explanation for poor progno

291 Tobacco smoking was the major influence on mutational bu

292 eristics, especially alcohol consumption and tobacco smoking, we examined promoter methylation of the

293 Survey data that did not report daily tobacco smoking were adjusted using the average relation

294 Infants exposed to tobacco smoking were approximately half as likely to dev

295 Median pack-years of tobacco smoking were lower among p16-positive than p16-n

296 DA) system drives the reinforcing effects of tobacco smoking, whereas the mesocortical DA system-incl

297 gh concentrations of nicotine resulting from tobacco smoking will cause an abnormal activation, a des

298 Tobacco smoking with a water pipe or hookah is increasin

299 ng with gastresophageal reflux, obesity, and tobacco smoking with genome-wide significance.

300 Clinical observations have linked tobacco smoking with increased type 2 diabetes risk.